We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in our Benign Hematology. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured

Journal Scan / Research · November 15, 2020

Lower Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban vs Warfarin in Patients With AF

Circulation: Cardiovascular Quality and Outcomes

 

Additional Info

Circulation: Cardiovascular Quality and Outcomes
Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF–TIMI 48 Trial
Circ Cardiovasc Qual Outcomes 2020 Nov 05;[EPub Ahead of Print], K Vilain, H Li, WJ Kwong, EM Antman, CT Ruff, E Braunwald, DJ Cohen, RP Giugliano, EA Magnuson,

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading